Catalyst Wire Dossier Catalyst Wire Dossier

Trogarzo (ibalizumab)

ibalizumab · Theratechnologies
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Trogarzo (ibalizumab), covering 2026-01-02 to 2026-01-02. Get the full timeline:

Most recent: Clinical Trial Update: A Prospective and Retrospective Observational Study of Multidrug-Resistant Patient Outcomes With and Without Ibalizumab

See pricing